Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
Gabriel A. Rabinovich(Consejo Nacional de Investigaciones Científicas y Técnicas), Stefano Iacobelli, Fu‐Tong Liu(University of California, Davis), Roberto Paganelli(Saint Camillus International University of Health and Medical Sciences), Linda G. Baum(University of California, Los Angeles), Nicola Tinari(University of Chieti-Pescara), Clara Natoli(Kliniken Essen-Mitte)
Cited by 530
Related Papers
Turning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation
|Nature reviews. Immunology|2009|895
Galectins: structure, function and therapeutic potential
|Expert Reviews in Molecular Medicine|2008|861
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Increased cytokine production in mononuclear cells of healthy elderly people
|European Journal of Immunology|1993|650
Pathogenesis of tendinopathies: inflammation or degeneration?
|Arthritis Research & Therapy|2009|570